Sandu Pharmaceuticals Ltd

Tue 17/11/2026,16:1:0 | BSE : SANDUPHQ

₹36.55-0.38 (-1.03%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 36.75

Previous Close

₹ 36.93

Volume

3506

Mkt Cap ( ₹ Cr)

₹ 35.31

High

₹ 37.98

Low

₹ 36.30

52 Week High

₹ 50.00

52 Week Low

₹ 30.00

Book Value Per Share

₹ 45.44

Dividend Yield

₹ 2.73

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Sandu Pharmaceuticals Ltd

Your Vote -

Buy

33.33%

Hold

33.33%

Sell

33.33%

33.33%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Sandu Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sandu Pharma. Q2 net profit jumps 51.92% at Rs 0.79 cr

    16 Nov 2026, 5:20PM The company reported standalone net profit of Rs 0.79 crore for the quarter ended September 30, 2026 as compared to Rs 0.52 crore in the same period l
  • Sandu Pharma. - Statement Of Deviation And Variation Of Funds For Q Ended 30Th September 2026

    14 Nov 2026, 7:06PM statement of deviation and variation of funds for q ended 30th sept 2026
  • Sandu Pharma. - Financial Results For Q And Half Year Ended 30Th Sept 2026

    14 Nov 2026, 6:57PM Results for Q and half year ended 30th sept 2026
  • Sandu Pharma. - Board Meeting Outcome for Outcome Of The Board Meeting Dated 14Th November 2026

    14 Nov 2026, 6:53PM Outcome of the Board Meeting dated 14th November 2026
  • Sandu Pharma. - Board Meeting Intimation for Approval Of Unaudited Financials For Quarter And Half Year Ended 30Th September

    4 Nov 2026, 3:42PM Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to conside
  • Sandu Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    17 Oct 2026, 2:20PM As of September 2026, 37.79% is owned by Indian Promoters and 62.21% by Public. <p align=justify> Top five Promoters holding highest number of shares
  • Sandu Pharma. - Intimation Regarding Change In Name Of Director From Dr Neeti Madan Kapre To Dr Neeti Gupta.

    9 Oct 2026, 11:40AM Intimation about change in name of Director from Dr Neeti Madan Kapre to Dr Neeti Gupta
  • Sandu Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Oct 2026, 10:55AM compliance certificate under Reg 74(5) of SEBI(DP) Regulation for Q ended 30th September 2026
  • Sandu Pharma. - Intimation To The Holders Of Physical Securities To Furnish PAN And KYC Details

    30 Sep 2026, 12:18PM Intimation to the holders of Physical Securities to furnish PAN and KYC details
  • Sandu Pharma. - Announcement under Regulation 30 (LODR)-Change in Directorate

    12 Sep 2026, 4:17PM 1. Redesignation of shri Balram Viswanathan (DIN :10245195)as Chairman and Managing Director of the company.\r\n2.Appointment of Dr Smt Neeti Kapre (
  • Sandu Pharma. - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

    12 Sep 2026, 3:15PM Appointment of M/s Dave & Dave Chartered Accountant as Statutory Auditor of the Company approved by shareholders in 41st Annual General Meeting
  • Sandu Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    12 Sep 2026, 2:56PM 41st Annual General Meeting scrutinizers Report
  • Sandu Pharma. - Shareholder Meeting / Postal Ballot-Outcome of AGM

    11 Sep 2026, 7:29PM Proceedings of the 41st Annual General Meeting held on Friday 11th september 2026 at 04:30 pm
  • Sandu Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    12 Sep 2026, 2:56PM 41st Annual General Meeting scrutinizers Report
  • Sandu Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    12 Sep 2026, 2:56PM 41st Annual General Meeting scrutinizers Report
  • Sandu Pharma. - Announcement Under Regulation 30-Letter To Shareholder On Annual Report Weblink Whose Email Ids Are Not Regis

    19 Aug 2026, 5:42PM Letters to shareholders on annual report weblink whose email ids are not registered with the company/RTA
  • Sandu Pharma. - Reg. 34 (1) Annual Report.

    19 Aug 2026, 5:39PM 41st Annual Report of Sandu Pharmaceuticals Limited
  • Sandu Pharma. - Annual General Meeting To Be Held On 11Th September 2026 At 04:30 Pm Through Video Conferencing ('VC')/ Othe

    19 Aug 2026, 5:33PM Intimation about Annual General Meeting

Key fundamentals

Evaluate the intrinsic value of Sandu Pharmaceuticals Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 43.6734 42.0172 40.5953 39.2444 36.4746
Liabilities 43.6734 42.0172 40.5953 39.2444 36.4746
Equity 9.661 9.661 9.661 9.661 8.8107
Gross Profit 3.0002 2.7622 2.2973 2.4893 2.874
Net Profit 1.7662 1.5489 1.4606 1.5239 1.5893
Cash From Operating Activities 6.1155 0.9504 0.7614 0.2212 0.9487
NPM(%) 2.52 2.3 2.17 2.33 2.42
Revenue 69.9345 67.1924 67.2807 65.349 65.5005
Expenses 66.9343 64.4302 64.9834 62.8597 62.6265
ROE(%) 4.02 3.52 3.32 3.47 3.62

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sandu Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 770.00 -1.91 15.26 20.86 -26.19 0.65
Lotus Eye Hospital and Institute Ltd 103.25 1.03 477.09 76.01 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 9.00 0.11 0.00 157.82 -39.50 0.00
Astec Lifesciences Ltd 561.45 1.33 0.00 81.44 -363.14 0.00

Company Info

The name "Sandu" leads in this roll call of honour. 10th May 1899 was the day Sandu Brothers chose to revolutionise the manufacture of Ayurvedic medicines. Commitment to the spread of Ayurveda and bringing health even to the poor were the lofty ideals that have been the foundation of the success of Sandu. High quality made Sandu medicines popular. Started on 10th May 1899 at Thakurdwar, Mumbai, the factory was later shifted to Chembur to cater to growing demand. Sandu is now a name established throughout India and has earned acceptance even beyond its borders and not in the Indian diaspora alone. Over 120 years, the secret of Sandu's success lies in our commitment to quality and firm adherence to the basic tenets of Ayurveda. Today, the fourth generation of Sandu at the helm implements a seamless confluence between tradition and modern pharmaceutical practices. We are growing, but without compromising on the quality in any way.Sandu is a benchmark of Quality amongst doctors, practitioners, and common people alike. Our commitment to quality is reflected in the ISO 9001:2000 certification we have earned for our Group operations which include our manufacturing units at New Mumbai and Goa as well as our full-fledged research unit - Sandu Research Foundation Pvt Ltd. While we rigorously follow traditional formulations, our manufacturing processes are totally aseptic and state-of-the-art with no human contact during the manufacturing process. Today, when allopathic medicines dominate the market, Sandu takes deserved pride in being known as the manufacturer of Ayurvedic Medicines with Visible Efficacy.

The name "Sandu" leads in this roll call of honour. 10th May 1899 was the day Sandu Brothers chose to revolutionise the manufacture of Ayurvedic medicines. Commitment to the spread of Ayurveda and bringing health even to the poor were the lofty ideals that have been the foundation of the success of Sandu. High quality made Sandu medicines popular. Started on 10th May 1899 at Thakurdwar, Mumbai, the factory was later shifted to Chembur to cater to growing demand. Sandu is now a name established throughout India and has earned acceptance even beyond its borders and not in the Indian diaspora alone. Over 120 years, the secret of Sandu's success lies in our commitment to quality and firm adherence to the basic tenets of Ayurveda. Today, the fourth generation of Sandu at the helm implements a seamless confluence between tradition and modern pharmaceutical practices. We are growing, but without compromising on the quality in any way.Sandu is a benchmark of Quality amongst doctors, practitioners, and common people alike. Our commitment to quality is reflected in the ISO 9001:2000 certification we have earned for our Group operations which include our manufacturing units at New Mumbai and Goa as well as our full-fledged research unit - Sandu Research Foundation Pvt Ltd. While we rigorously follow traditional formulations, our manufacturing processes are totally aseptic and state-of-the-art with no human contact during the manufacturing process. Today, when allopathic medicines dominate the market, Sandu takes deserved pride in being known as the manufacturer of Ayurvedic Medicines with Visible Efficacy.

Parent Organisation

Sandu Pharmaceuticals Ltd.

Founded

15/11/1985

Managing Director

NSE Symbol

FAQ